US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post Properties

65.02

0.0000

Volume:- -

Turnover:- -

Market Cap:240.17B

PE:45.47

High:65.02

Open:65.02

Low:65.02

Close:65.02

52wk High:65.02

52wk Low:65.02

Shares:3.69B

Float Shares:53.51M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):1.43

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited

Canaccord Genuity Sticks to Their Buy Rating for Praemium Ltd (PPS)

Press Release: Piramal Pharma Limited Announces Results for Q1 FY27

Ord Minnett Sticks to Their Buy Rating for Praemium Ltd (PPS)

Press Release: Piramal Pharma's Fy2026 Annual Report Showcases Global Scale, Innovation-led Growth and Sustainability Milestones

Praemium Ltd (PPS) Gets a Buy from Bell Potter

Praemium Ltd (PPS) Gets a Buy from Canaccord Genuity

Ord Minnett Keeps Their Buy Rating on Praemium Ltd (PPS)

Praemium Ltd (PPS) Receives a Buy from Ord Minnett

Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update

Press Release: Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update

Indonesia Gives Citizens Six Months to Return Assets Held Abroad

Purbaya Reaffirms No Asset Hunt for Tax Amnesty Joiners

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting

Ord Minnett Reaffirms Their Buy Rating on Praemium Ltd (PPS)

Praemium Ltd (PPS) Gets a Buy from RBC Capital

Bell Potter Remains a Buy on Praemium Ltd (PPS)

Praemium Ltd (PPS) Receives a Buy from Ord Minnett

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PPS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PPS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPS\",,,,,undefined,":{"symbol":"PPS","market":"US","secType":"STK","nameCN":"Post Properties","latestPrice":65.02,"timestamp":1787342400000,"preClose":65.02,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":53509619,"shares":3693772279,"eps":1.43,"marketStatus":"Market Closed","change":0,"latestTime":"08-21 16:00:00 EDT","open":65.02,"high":65.02,"low":65.02,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.43,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":65.02,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPS\",,,,,undefined,":{"symbol":"PPS","floatShares":53509619,"roa":"--","roe":"--","lyrEps":0,"shares":3693772279,"dividePrice":0,"high":65.02,"amplitude":0,"preClose":65.02,"low":65.02,"week52Low":65.02,"pbRate":"--","week52High":65.02,"institutionHeld":0.9735,"latestPrice":65.02,"eps":1.43,"divideRate":0,"volume":0,"delay":0,"ttmEps":1.43,"open":65.02,"prevYearClose":65.02,"prevWeekClose":65.02,"prevMonthClose":65.02,"prevQuarterClose":65.02,"fiveDayClose":65.02,"twentyDayClose":65.02,"sixtyDayClose":65.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-10-31","symbol":"PPS","fiscalQuarterEnding":null,"expectedEps":0.81,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1477886400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-05-02","symbol":"PPS","fiscalQuarterEnding":null,"expectedEps":0.78,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1462161600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-02-04","symbol":"PPS","fiscalQuarterEnding":null,"expectedEps":0.77,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1454562000000,"reportTimeType":"post","actualEps":0.78},{"market":"US","date":"2015-11-02","symbol":"PPS","fiscalQuarterEnding":null,"expectedEps":0.74,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1446440400000,"reportTimeType":"post","actualEps":0.76},{"market":"US","date":"2015-08-03","symbol":"PPS","fiscalQuarterEnding":null,"expectedEps":0.73,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1438574400000,"reportTimeType":"post","actualEps":0.74}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660534494","title":"Press Release: Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited","url":"https://stock-news.laohu8.com/highlight/detail?id=2660534494","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660534494?lang=en_us&edition=fundamental","pubTime":"2026-08-19 03:37","pubTimestamp":1787081820,"startTime":"0","endTime":"0","summary":"-- Yapan Bio Private Limited specializes in process development,characterization, and phase I and II GMP manufacturing services for. -- Piramal has held a stake in Yapan Bio since 2021, enabling the Company to. provide a broad range of capabilities across biologics development and. -- This acquisition transforms Yapan Bio from Piramal's associate company to. its subsidiary, enhancing the Company's ability to offer complex,","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EES","BK4139","TM","BK4099","BK4585","BK4588","CDMO","BK4604","03160","PPS","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655485688","title":"Canaccord Genuity Sticks to Their Buy Rating for Praemium Ltd (PPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2655485688","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655485688?lang=en_us&edition=fundamental","pubTime":"2026-07-30 07:36","pubTimestamp":1785368206,"startTime":"0","endTime":"0","summary":"In a report released today, Warren Jeffries from Canaccord Genuity maintained a Buy rating on Praemium Ltd, with a price target of A$1.20. Accordin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-their-buy-rating-for-praemium-ltd-pps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-their-buy-rating-for-praemium-ltd-pps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655813276","title":"Press Release: Piramal Pharma Limited Announces Results for Q1 FY27","url":"https://stock-news.laohu8.com/highlight/detail?id=2655813276","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655813276?lang=en_us&edition=fundamental","pubTime":"2026-07-30 03:28","pubTimestamp":1785353280,"startTime":"0","endTime":"0","summary":"MUMBAI, India, July 29, 2026 /CNW/ -- Piramal Pharma Limited  , a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the First Quarter  ended 30  June 2026.Consolidated Financial Highlights. PAT                 15 %Note: Exceptional items in Q1FY26 include one-time insolvency proceeds received from a claim filed against a third-party supplier of our complex hospital generics business, with the NCLT in November 2023Key Highlights-- Revenue: Healthy 17% revenue growth, supported by strong performance. -- EBITDA Margin: EBITDA increased by 72%, with EBITDA margin expanding by. approximately 400 basis points to 12.5%, reflecting improved operating. -- Improved Operating Performance: Higher capacity utilization, operating. leverage, pricing discipline and operational excellence supported EBITDA. -- Best-in-Class Quality: Sellersville facility in the US received an. Establishment Inspection Report from the US FDA, successfu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","BK4084","BK4604","BK4022","BK4139","LU0208291251.USD","LU0320765489.SGD","BK4232","BK4099","PCH","R","IE00BN8TJ469.HKD","FPWR","03160","IE00BD4GTW91.USD","IE00BLSP4452.SGD","BK4221","IE00BD4GTV84.USD","PPL","IE00BD4GTT62.SGD","CDMO","TM","LU0070302665.USD","BK4555","LU1093756325.SGD","BK4585","IE00BLSP4239.USD","LU2449327464.USD","LU0787776722.HKD","LU1093756168.USD","BK4588","LU0683600562.USD","PPS","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653797062","title":"Ord Minnett Sticks to Their Buy Rating for Praemium Ltd (PPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2653797062","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653797062?lang=en_us&edition=fundamental","pubTime":"2026-07-23 09:05","pubTimestamp":1784768728,"startTime":"0","endTime":"0","summary":"In a report released today, Anthony Hoo from Ord Minnett maintained a Buy rating on Praemium Ltd, with a price target of A$1.05. Hoo covers the Fin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ord-minnett-sticks-to-their-buy-rating-for-praemium-ltd-pps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ord-minnett-sticks-to-their-buy-rating-for-praemium-ltd-pps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649980881","title":"Press Release: Piramal Pharma's Fy2026 Annual Report Showcases Global Scale, Innovation-led Growth and Sustainability Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2649980881","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649980881?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:36","pubTimestamp":1783427760,"startTime":"0","endTime":"0","summary":"MUMBAI, India, July 7, 2026 /CNW/ -- Piramal Pharma Limited   , a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global platform, investing in differentiated capabilities, advancing sustainability, and delivering quality across operations. The report reflects Piramal Pharma's continued commitment to improving patient outcomes through science-led innovation, operational excellence and quality, while building a resilient global platform that serves customers across regulated markets worldwide.During FY2026, Piramal Pharma reported revenue from operations of 8,869 crore, supported by a diversified business model with 17 global development and manufacturing facilities, commercial presence across more than 100 countries. Approximately 66% of the Company's revenue was generated from regulated markets, reinforcing its strong global footprint.Ms. Nandini Piramal, Chairperson of Piramal Pharma Limited, ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","BK4081","PPS","IE00BLSP4239.USD","BK4585","LU0070302665.USD","LU2449327464.USD","CDMO","PPL","LU1093756325.SGD","IE00BD4GTV84.USD","IE00BBT3K403.USD","IE00BD4GTT62.SGD","FPWR","LU0208291251.USD","LU0320765489.SGD","LU1093756168.USD","LU0787776722.HKD","BK4588","IE00BLSP4452.SGD","BK4139","IE00BN8TJ469.HKD","IE00BD4GTW91.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648634762","title":"Praemium Ltd (PPS) Gets a Buy from Bell Potter","url":"https://stock-news.laohu8.com/highlight/detail?id=2648634762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648634762?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:05","pubTimestamp":1783040735,"startTime":"0","endTime":"0","summary":"In a report released today, Hayden Nicholson from Bell Potter maintained a Buy rating on Praemium Ltd, with a price target of A$1.20. Nicholson cov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/praemium-ltd-pps-gets-a-buy-from-bell-potter-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/praemium-ltd-pps-gets-a-buy-from-bell-potter-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643456228","title":"Praemium Ltd (PPS) Gets a Buy from Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2643456228","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643456228?lang=en_us&edition=fundamental","pubTime":"2026-06-15 07:35","pubTimestamp":1781480114,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Warren Jeffries maintained a Buy rating on Praemium Ltd yesterday and set a price target of A$1.40. According to TipRanks...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/praemium-ltd-pps-gets-a-buy-from-canaccord-genuity-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/praemium-ltd-pps-gets-a-buy-from-canaccord-genuity-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642447040","title":"Ord Minnett Keeps Their Buy Rating on Praemium Ltd (PPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642447040","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642447040?lang=en_us&edition=fundamental","pubTime":"2026-06-11 09:51","pubTimestamp":1781142687,"startTime":"0","endTime":"0","summary":"In a report released today, Anthony Hoo from Ord Minnett maintained a Buy rating on Praemium Ltd, with a price target of A$1.05. Hoo covers the Fin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ord-minnett-keeps-their-buy-rating-on-praemium-ltd-pps-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ord-minnett-keeps-their-buy-rating-on-praemium-ltd-pps-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959089","title":"Praemium Ltd (PPS) Receives a Buy from Ord Minnett","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959089","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959089?lang=en_us&edition=fundamental","pubTime":"2026-06-02 09:10","pubTimestamp":1780362649,"startTime":"0","endTime":"0","summary":"Ord Minnett analyst Anthony Hoo maintained a Buy rating on Praemium Ltd today and set a price target of A$1.05. According to TipRanks, Hoo is a 4-s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/praemium-ltd-pps-receives-a-buy-from-ord-minnett-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/praemium-ltd-pps-receives-a-buy-from-ord-minnett-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635141297","title":"Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635141297","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635141297?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:30","pubTimestamp":1778758200,"startTime":"0","endTime":"0","summary":"Woburn, MA, May  14, 2026  (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) (the \"Company\"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therap","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3294804/0/en/Biofrontera-Inc-Reports-First-Quarter-2026-Financial-Results-and-Provides-a-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AV","PDT","BK4007","BFRI","PPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635114247","title":"Press Release: Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635114247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635114247?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616300,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., May 12, 2026  -- Rezolute, Inc.  , a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism , today reported financial results and provided a business update for the three months ended March 31, 2026.-- In May 2026, expanded analyses from the Phase 3 sunRIZE study of. ersodetug in patients with congenital HI were presented via oral. presentation at the Pediatric Endocrine Society  2026 Annual Meeting. by Diva D. De León-Crutchlow, M.D., M.S.C.E., Chief of the Division. of Endocrinology and Diabetes, Director of the Congenital Hyperinsulinism. Center at Children's Hospital of Philadelphia, and Principal Investigator. -- In addition to the previously reported topline results, the. and consistent improvements in glycemic control in ersodetug. treatment arms compared to placebo, across multiple pre-specified. -- Average daily percent time in hypoglycemia by CGM:. of 50-65%  and 50-80% , compared to placebo. -- Average b","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","LU2125154935.USD","BK4588","BK4139","LU2360032135.SGD","FAS","HI","LU2125154778.USD","BK4585","BK4161","LU0029874061.USD","PPS","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634299084","title":"Indonesia Gives Citizens Six Months to Return Assets Held Abroad","url":"https://stock-news.laohu8.com/highlight/detail?id=2634299084","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634299084?lang=en_us&edition=fundamental","pubTime":"2026-05-12 12:08","pubTimestamp":1778558895,"startTime":"0","endTime":"0","summary":"The former Chair of the Board of Commissioners of the Deposit Insurance Corporation  stated that there would be consequences for those who do not comply with this requirement, including restrictions on business access. \"So, having money abroad will no longer enable them to do business here,\" he added.","market":"nz","thumbnail":"https://statik.tempo.co/data/2026/05/11/id_1472726/1472726_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/05/11/id_1472726/1472726_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2103172/indonesia-gives-citizens-six-months-to-return-assets-held-abroad","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2103172/indonesia-gives-citizens-six-months-to-return-assets-held-abroad","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["PPS","PPS.AU","DJP","BK7503","BK7016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634288941","title":"Purbaya Reaffirms No Asset Hunt for Tax Amnesty Joiners","url":"https://stock-news.laohu8.com/highlight/detail?id=2634288941","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634288941?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:23","pubTimestamp":1778494991,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - Finance Minister Purbaya Yudhi Sadewa said the government will not pursue the assets of taxpayers who joined Indonesia’s tax amnesty program through the Voluntary Disclosure Progra","market":"fut","thumbnail":"https://statik.tempo.co/data/2026/05/11/id_1472726/1472726_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/05/11/id_1472726/1472726_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2103067/purbaya-reaffirms-no-asset-hunt-for-tax-amnesty-joiners","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2103067/purbaya-reaffirms-no-asset-hunt-for-tax-amnesty-joiners","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["PPS","PPS.AU","BK7016","BK7503","DJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632645785","title":"Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2632645785","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632645785?lang=en_us&edition=fundamental","pubTime":"2026-05-02 00:15","pubTimestamp":1777652100,"startTime":"0","endTime":"0","summary":"Includes results from additional continuous glucose monitoring (CGM)-based outcomes which demonstrate significant and consistent improvements in glycemic control in ersodetug treatment arms compared t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/01/3286124/0/en/Rezolute-Announces-Oral-Presentation-of-Results-From-its-Phase-3-sunRIZE-Study-of-Ersodetug-in-Patients-with-Congenital-Hyperinsulinism-at-the-Pediatric-Endocrine-Society-Annual-Me.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","LU2360032135.SGD","LU0029874061.USD","PPS","SOC","FAS","BK4213","BK4161","LU2125154935.USD","LU2125154778.USD","BK4588","BK4585","HI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629070506","title":"Ord Minnett Reaffirms Their Buy Rating on Praemium Ltd (PPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629070506","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629070506?lang=en_us&edition=fundamental","pubTime":"2026-04-23 09:38","pubTimestamp":1776908283,"startTime":"0","endTime":"0","summary":"In a report released today, Anthony Hoo from Ord Minnett maintained a Buy rating on Praemium Ltd, with a price target of A$1.05. According to TipRa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ord-minnett-reaffirms-their-buy-rating-on-praemium-ltd-pps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ord-minnett-reaffirms-their-buy-rating-on-praemium-ltd-pps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614088809","title":"Praemium Ltd (PPS) Gets a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2614088809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614088809?lang=en_us&edition=fundamental","pubTime":"2026-02-25 18:16","pubTimestamp":1772014597,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Wei-Weng Chen from RBC Capital maintained a Buy rating on Praemium Ltd, with a price target of A$1.10. The company’...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/praemium-ltd-pps-gets-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/praemium-ltd-pps-gets-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","PPS","LU0310800379.SGD","LU1267930573.SGD","LU0029864427.USD","LU0708994859.HKD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614720555","title":"Bell Potter Remains a Buy on Praemium Ltd (PPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614720555","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614720555?lang=en_us&edition=fundamental","pubTime":"2026-02-25 09:05","pubTimestamp":1771981550,"startTime":"0","endTime":"0","summary":"Bell Potter analyst Hayden Nicholson maintained a Buy rating on Praemium Ltd today and set a price target of A$1.20. Nicholson covers the Financial...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bell-potter-remains-a-buy-on-praemium-ltd-pps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bell-potter-remains-a-buy-on-praemium-ltd-pps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613208751","title":"Praemium Ltd (PPS) Receives a Buy from Ord Minnett","url":"https://stock-news.laohu8.com/highlight/detail?id=2613208751","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613208751?lang=en_us&edition=fundamental","pubTime":"2026-02-24 08:56","pubTimestamp":1771894560,"startTime":"0","endTime":"0","summary":"Ord Minnett analyst Anthony Hoo maintained a Buy rating on Praemium Ltd today and set a price target of A$1.15. According to TipRanks, Hoo is ranke...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/praemium-ltd-pps-receives-a-buy-from-ord-minnett-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/praemium-ltd-pps-receives-a-buy-from-ord-minnett-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}